Subgroup analysis by prior non-liposomal irinotecan therapy in NAPOLI-1: A phase 3 study of nal-IRI±5-fluorouracil/leucovorin in patients with metastatic pancreatic ductal adenocarcinoma previously treated with gemcitabine-based therapy

This article has no abstract
Epistemonikos ID: 53d5f2bad4bef98f8414bd542caa965e5fbd99b7
First added on: Feb 08, 2025